Patents by Inventor Troy A. Luster

Troy A. Luster has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160311886
    Abstract: Disclosed are new phosphatidylserine binding constructs with surprising combinations of properties, and a range of diagnostic and therapeutic conjugates thereof. The new constructs effectively bind phosphatidylserine targets in disease and enhance their destruction, and can also specifically deliver attached imaging or therapeutic agents to the disease site. Also disclosed are methods of using the new construct compositions, therapeutic conjugates and combinations thereof in tumor vasculature targeting, cancer diagnosis and treatment, and for treating viral infections and other diseases.
    Type: Application
    Filed: July 12, 2016
    Publication date: October 27, 2016
    Inventors: Phillip E. Thorpe, Troy A. Luster, Steven W. King
  • Publication number: 20160015826
    Abstract: Disclosed are new phosphatidylserine binding constructs with surprising combinations of properties, and a range of diagnostic and therapeutic conjugates thereof. The new constructs effectively bind phosphatidylserine targets in disease and enhance their destruction, and can also specifically deliver attached imaging or therapeutic agents to the disease site. Also disclosed are methods of using the new construct compositions, therapeutic conjugates and combinations thereof in tumor vasculature targeting, cancer diagnosis and treatment, and fir treating viral infections and other diseases.
    Type: Application
    Filed: February 2, 2015
    Publication date: January 21, 2016
    Inventors: Philip E. Thorpe, Troy A. Luster, Steven W. King
  • Patent number: 8956616
    Abstract: Disclosed are new phosphatidylserine binding constructs with surprising combinations of properties, and a range of diagnostic and therapeutic conjugates thereof. The new constructs effectively bind phosphatidylserine targets in disease and enhance their destruction, and can also specifically deliver attached imaging or therapeutic agents to the disease site. Also disclosed are methods of using the new construct compositions, therapeutic conjugates and combinations thereof in tumor vasculature targeting, cancer diagnosis and treatment, and for treating viral infections and other diseases.
    Type: Grant
    Filed: January 24, 2006
    Date of Patent: February 17, 2015
    Assignees: Board of Regents, The University of Texas System, Peregrine Pharmaceuticals, Inc.
    Inventors: Philip E. Thorpe, Troy A. Luster, Steven W. King
  • Publication number: 20060228299
    Abstract: Disclosed are new phosphatidylserine binding constructs with surprising combinations of properties, and a range of diagnostic and therapeutic conjugates thereof. The new constructs effectively bind phosphatidylserine targets in disease and enhance their destruction, and can also specifically deliver attached imaging or therapeutic agents to the disease site. Also disclosed are methods of using the new construct compositions, therapeutic conjugates and combinations thereof in tumor vasculature targeting, cancer diagnosis and treatment, and for treating viral infections and other diseases.
    Type: Application
    Filed: January 24, 2006
    Publication date: October 12, 2006
    Inventors: Philip Thorpe, Troy Luster, Steven King